Trials / Not Yet Recruiting
Not Yet RecruitingNCT06391580
A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit
A Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 192 (estimated)
- Sponsor
- Sinclair Pharmaceuticals Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Poly-L-lactin Acid (PLLA) Based Facial Injectable | Poly-L-lactin Acid (PLLA) Based Facial Injectable |
Timeline
- Start date
- 2024-04-30
- Primary completion
- 2024-04-30
- Completion
- 2025-04-30
- First posted
- 2024-04-30
- Last updated
- 2024-04-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06391580. Inclusion in this directory is not an endorsement.